Wyeth/Aviron FluMist Pulmonary Safety Requires More Analysis - FDA Cmte.

Approval of Wyeth/Aviron's intranasal flu vaccine FluMist will likely hinge on further analysis of the pulmonary safety data for the product and information about interactions with concurrent immunizations following a review by FDA's Vaccines & Related Biological Products Advisory Committee July 27.